Long-term use of antipsychotic Risperdal in children linked to reduced bone mass
Long-term use of the antipsychotic drug Risperdal in children can reduce bone mass and prevent bone growth, according to a new study presented at the American Society of Clinical Psychopharmacology’s annual meeting. Similar results were found in children treated long-term
Controversial analysis suggests Actos may help protect users from dementia
The type 2 diabetes drug Actos could help ward off dementia, a new analysis has found. However, researcher say more analysis is needed as well as adverse side effects addressed before the medication can be recommended as a preventative measure.
Transvaginal mesh lawsuits continue three years after FDA warning
It has been three years since the Food and Drug Administration (FDA) issued a Safety Communication warning the public that complications with transvaginal mesh used to treat pelvic floor disorders including pelvic organ prolapse and stress urinary incontinence were not
Lipitor side effects lawsuits mounting against Pfizer
Lawsuits have been mounting against drugmaker Pfizer alleging the company failed to warn the public that its top selling cholesterol-lowering statin Lipitor could cause type 2 diabetes.
Hormonal contraceptives may increase risk of gestational diabetes
Women who use contraceptives that contain hormones before they become pregnant may be at greater risk for developing gestational diabetes once they do get pregnant, according to a new study.
Pre-diabetes diagnoses benefit drug companies more than patients
Non-diabetics with higher-than-recommended blood sugar levels and thus at risk for developing type 2 diabetes are considered pre-diabetic, however classifying large numbers of people with pre-diabetes offers more benefit to drug companies than those diagnosed with the condition, researchers argue.
New blood clot warning added to safety labels of testosterone replacement therapies
The safety labels of testosterone replacement treatments have been updated to include warnings of an increased risk of life threatening blood clots. The update comes on the heels of a Food and Drug Administration (FDA) safety alert notifying the public
Fresenius faces more lawsuits over generic drugs
Fresenius Kabi, one of four business segments of the worldwide dialysis service and product provider Fresenius Medical Care, is being accused by drugmaker Cubist Pharmaceuticals of infringing on four patents for the intravenous antibiotic Cubicin, used to treat skin and